Merck & Co has completed its takeover of Schering-Plough in a $41 billion deal that was first proposed in March this year. As a result, it gains control of the Intervet/Schering-Plough Animal Health (I/SPAH) operation, but this could change again early next year. "On day one for the new Merck, ...
Please Login to read the full article.
